Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH). It stimulates the pituitary gland to release growth hormone, which can increase IGF-1 levels.
Research and medical interest includes:
Growth hormone and IGF-1 regulation
Visceral abdominal fat metabolism
Body-composition changes
Metabolic pathways
Important: Unlike many research peptides, tesamorelin does have an FDA-approved prescription use: reducing excess abdominal fat in adults with HIV and lipodystrophy. It is not FDA-approved for general weight loss, anti-aging, or routine body contouring, and it should be used under appropriate medical supervision.
